Acute liver injury associated with the use of ebrotidine, a new H 2 -receptor antagonist
Authors:
- Raúl J AndradeRARaúl J Andrade
- M.Isabel LucenaM.Isabel Lucena
- Rafael Martin-VivaldiRMRafael Martin-Vivaldi
- M.Carmen FernandezMFM.Carmen Fernandez
- Flor NoguerasFNFlor Nogueras
- Gloria PelaezGPGloria Pelaez
- Antonio Gomez-OutesAGAntonio Gomez-Outes
- M Dolores Garcia-EscañoMGM Dolores Garcia-Escaño
- Vicente BellotVBVicente Bellot
- Antonio HervásAHAntonio Hervás
- Francisco CárdenasFCFrancisco Cárdenas
- Francisco BermudezFBFrancisco Bermudez
- 1 October 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (4) , 641-646
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Acute liver injury related to the use of niperotidineJournal of Hepatology, 1997
- A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United KingdomPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1997
- The risk of acute liver injury associated with cimetidine and other acid‐suppressing anti‐ulcer drugsBritish Journal of Clinical Pharmacology, 1997
- EbrotidineDrugs, 1996
- Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspectiveClinical Pharmacology & Therapeutics, 1995
- Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factorsArchives of internal medicine (1960), 1994
- Amoxicillin-clavulanate potassium-associated cholestasisGastroenterology, 1989
- Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonistsThe American Journal of Medicine, 1987
- Possible Ranitidine HepatotoxicityAnnals of Internal Medicine, 1984